Nystatin

Y. Vivian Tsai, Pharm.D., Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

  • Oropharyngeal candidiasis
  • Vulvovaginal candidiasis — clinical/global use; nystatin vaginal formulations are not currently commercially marketed in the U.S. and may require compounding.
    • An alternative intravaginal treatment when azoles are unsuitable, including cases of C. glabrata infection.[1][5]
  • Cutaneous candidiasis
  • Nonesophageal gastrointestinal mucosal candidiasis

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: November 7, 2026